VLDLR and atherosclerosis: Of note, we previously reported that IL-17A promotes endothelial cell activation but not atherosclerosis (54); that deficiency of mRNA-decaying protein tristetraprolin (TTP) in bone marrow cells promote strong systemic inflammation but not atherosclerosis in low-density lipoprotein receptor (LDLR)-deficient mice (55).